Skip to main content
森萱医药 logo

森萱医药 — Investor Relations & Filings

Ticker · 920946 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 417 across all filing types
Latest filing 2025-02-13 Regulatory Filings
Country CN China
Listing Beijing Stock Exchange 920946

About 森萱医药

https://www.senxuan.cn/

Jiangsu Senxuan Pharmaceutical Co., Ltd. specializes in the research, development, and production of pharmaceutical intermediates, active pharmaceutical ingredients (APIs), and specialized fine chemicals. The company’s product portfolio includes key intermediates for antiviral medications, such as those used in the treatment of HIV, and anticonvulsant agents like Primidone. Additionally, it produces high-purity chemical solvents including 1,4-dioxane and 1,3-dioxolane for diverse industrial applications. Senxuan Pharmaceutical maintains a focus on advanced chemical synthesis and large-scale manufacturing capabilities, adhering to international quality standards to support the global life sciences and chemical sectors. Its operations are characterized by a commitment to technical innovation and the supply of critical chemical building blocks for complex therapeutic formulations.

Recent filings

Filing Released Lang Actions
关于投资者关系活动记录表的公告
Regulatory Filings Classification · 95% confidence The document is titled as an "投资者关系活动记录表" which translates to "Investor Relations Activity Record." It details a specific investor relations event held on February 13, 2025, including participants, questions asked, and company responses. The content focuses on company innovation, product sales, financial performance, and strategic outlook, typical of an investor Q&A session or meeting summary. The document length is 2209 characters, which is relatively short and does not contain formal financial statements or comprehensive financial data. It is not an earnings release or a full financial report but rather a record of an investor relations activity. This fits best under the category of Regulatory Filings (RNS) as a general regulatory announcement or investor relations disclosure that does not fit other specific categories.
2025-02-13 Chinese
2025年第一次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled as a resolution announcement for the "2025 First Extraordinary General Meeting (EGM)" of Jiangsu Senxuan Pharmaceutical Co., Ltd. It details the meeting date, location, attendance, voting results on a specific agenda item regarding expected 2025 related party transactions, and includes legal opinions confirming the legality and validity of the meeting and resolutions. The document is an official announcement of the voting results from a shareholder meeting rather than the meeting materials or presentations themselves. It is not a full annual or interim report, nor an earnings release or management discussion. The content fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is short (1837 characters), consistent with a voting results announcement rather than a full report.
2025-01-15 Chinese
2025年第一次临时股东大会法律意见书
Regulatory Filings
2025-01-15 Chinese
关于增加签字注册会计师及变更质量控制复核人的公告
Audit Report / Information Classification · 95% confidence The document is an announcement from Jiangsu Senxuan Pharmaceutical Co., Ltd. regarding changes in the signing certified public accountants and the quality control reviewer for the company's 2024 financial audit. It details the appointment of additional auditors and changes in quality control personnel, including their qualifications and independence. The document references the 2024 annual audit but does not contain any financial statements or substantive financial data itself. It is a formal announcement about audit personnel changes rather than the audit report or the annual report itself. The document length is short (1602 characters), and it serves as a regulatory announcement about audit personnel changes. Therefore, it fits best under Audit Report / Information (AR), which includes standalone audit reports and related audit information excluding full annual reports. FY 2024
2025-01-06 Chinese
第四届董事会第七次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolutions passed at the seventh meeting of the fourth board of directors of Jiangsu Senxuan Pharmaceutical Co., Ltd. It details the meeting date, attendance, agenda items, voting results, and references to related announcements on the Beijing Stock Exchange information disclosure platform. The content focuses on board meeting decisions, internal management system approvals, and plans for a shareholders' meeting. There is no financial data, earnings information, or audit content. The document is not a full report but an official announcement of board meeting resolutions. Therefore, it fits the category of Board/Management Information (MANG). The document length is short (2117 characters), consistent with a meeting resolution announcement rather than a full report.
2024-12-29 Chinese
关于预计2025年日常性关联交易的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from Jiangsu Senxuan Pharmaceutical Co., Ltd. regarding the expected related party transactions for the year 2025. It includes detailed information about the types and amounts of transactions expected, descriptions of related parties, their financial data, and the company's internal approval process for these transactions. The document is not a full financial report but rather a disclosure about anticipated related party transactions, including governance and compliance details. It does not contain comprehensive financial statements or quarterly/yearly financial results. It is a regulatory announcement about related party transactions, which typically falls under general regulatory filings. There is no indication that this is an annual report, audit report, earnings release, or any other specific financial report type. Therefore, the most appropriate classification is Regulatory Filings (RNS). The document length (11,977 characters) and content support this classification with high confidence.
2024-12-29 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.